Key points are not available for this paper at this time.
Paired syngeneic models help unravel the interplay between CAF and tumor immune evasion, highlighting the benefits of targeting fibroblast subpopulations to improve clinical responses to immunotherapy.
Jenkins et al. (Fri,) studied this question.